Two human prostate gland proteases were expressed in insect cells using recombinant baculovirus expression system. Prostate speci®c antigen (PSA) is an established serum marker of prostate cancer whereas the clinical utility of its close homologue, human glandular kallikrein (hK2) is presently unknown. The production levels using Trichoplusia ni cells were roughly 300 mg/l and 6 mg/l for hK2 and PSA, respectively. On western-blot we estimated the size for both proteins to be approximately 33 kDa which was consistent with PSA puri®ed from seminal plasma. Nine anti-PSA monoclonal antibodies (Mabs) out of 26 tested, representing ®ve independent epitopes, also reacted with hK2. The results obtained in this study may help in designing more accurate diagnostic assays for detection and monitoring of prostate cancer.
Introduction
Human prostate speci®c antigen PSA or hK3 according to a recently suggested nomenclature 1 is a 237 amino acid single chain glycoprotein with an apparent molecular mass of 33 kDa that belongs to the family of serine proteases. It is structurally highly similar (80%) to human glandular kallikrein (hK2). 2 The expression of both proteins is androgen dependent and mainly restricted to prostate tissue, although non-prostatic expression of both proteins has also been reported recently. 3±5 Circulating PSA in serum is the predominant tumor marker used for the diagnosis of patients with cancer of the prostate (CAP) and its subsequent monitoring. On the other hand, the usefulness of PSA to detect CAP is limited by the fact that serum PSA levels may also be elevated in subjects with benign prostate hyperplasia (BPH). In 1990 it was shown that puri®ed PSA forms complexes with a 1 -antichymotrypsin (ACT) in vitro. 6 It was later demonstrated that PSA-ACT in serum accounts for more than 50% of the total PSA immunoreactivity and that the proportion of the complex was higher in patients with prostate cancer than in those with benign prostatic hyperplasia. 7 In a study using an immuno¯uorimetric assay speci®cally designed to measure free PSA, it was concluded that free uncomplexed PSA in a clinically nonde®ned patient material constituted a minor fraction of PSA in serum. 8 Af®rmation of the improved discrimination of cancer and BPH were con®rmed using the free PSA assay together with assays designed to measure total PSA and PSA-ACT. 9 Due to the extensive homology between PSA and hK2, the present immunoassays developed for PSA may crossreact with hK2. The hK2 mRNA levels have been reported to be 10±50% of that of PSA mRNA in prostatic tissue.
10±12
The puri®cation and characterisation of the hK2 protein in body tissues and¯uids has been reported. 13 We have recently optimised an immunoassay for circulating hK2 concentrations.
14 This assay is based on the observed differences in the ability of anti-PSA-speci®c antibodies to recognise hK2 and PSA antigens expressed in Escherichia coli and BHK21 cells. 15±17 Here we report the cloning of PSA and hK2 cDNAs in insect cells (Spodoptera frugiperda and Trichoplusia ni ) using the baculovirus expression system (BEVS). The results from the epitope mapping of the expressed proteins are characterised with a large number of monoclonal antibodies raised against PSA puri®ed from seminal plasma.
Materials and methods

Plasmid constructs and fermentation
The cloning of the human KLK3-gene coding for PSA into vector pUC18PSAV1 and further to eucaryotic BHK21-cells has been described. 17 The recombinant baculovirus expression vector AcFAST-Bac-PSA was constructed from pUC18PSAV1 cut with restriction endonuclease BamHI essentially as described. 18 The gene KLK2 coding for hK2 was initially cloned as a polymerase chain reaction (PCR)-fragment into an E. coli vector pUC-19 and thereafter to an expression vector pKKtac 16, 19 using a human prostate cDNA library 20 as a template. The recombinant baculovirus expressing hK2 was constructed from pKKtac-hK2 similarly as described for hKLK3-gene resulting in AcFAST-Bac-hK2, see above. All recombinant-DNA work was carried out as described in Sambrook et al 21 using restriction and other DNAmodifying enzymes purchased from New England Biolabs.
The PSA and hK2 proteins were produced in suspension using the baculovirus technology in Spodoptera frugiperda (Sf 21) or Trichoplusia ni (High Five TM ) cells. Either spinner¯asks or Erlenmeyer¯asks were used in volumes from 20 ml to 800 ml using serum free media SF-900 II (Gibco-BRL) at 27 C, 120 rpm and cultivation/infection methods essentially as described. 22 Immunoreactivity, determination of af®nity constants, epitope mapping and Western-blotting
The production and characterisation of the monoclonal antibodies 5A10, 9B10, 2C1, 3C1, 10D7, 9E8, 2E9, 5F11, 7H2, 4H5, 7H10, 2H11 and 2H12 used in this study have been described earlier. 5, 23, 24 The monoclonal antibodies H50, H68, H117, H164 and H179 were obtained from Abbott Laboratories (Abbott Park, Illinois), antibody F5 25 was from Dr Chu and antibodies 6, 10, 19, 25, 30, 36 and 66 were obtained as a kind donation from Dr Olle Nilsson (CanAG Diagnostics, Go È teborg, Sweden). Immunoreactivity and af®nity constants were determined using different two-site combinations of capture antibody and europium chelate-labelled antibody with time-resolved uorometry as described by Pettersson et al. 23 The af®nity constants were measured according to the method of Scatchard.
26
The PSA puri®ed from seminal¯uid was obtained as described earlier. 24 The Western-blotting was carried out as described earlier for phage-expressed prostate speci®c antigen 15 using H117 as a primary antibody and peroxidase-labelled anti-mouse antibody as secondary antibody.
Results
The full-length recombinant baculoviruses expressing KLK2 or KLK3 genes coding for hK2 or PSA, respectively, were created in E. coli using a recently described homologous recombination system which utilise ef®cient transposition functions of transposon Tn7. 18 In both viruses (AcFAST-Bac-hK2 and AcFAST-Bac-PSA, respectively) the expression of foreign gene is controlled by the strong and late polyhedrin promoter of Autographa californica nuclear polyhedrosis virus. Figure 1 shows the time course of the production of PSA and hK2 using Trichoplusia ni High Five TM insect cells. As seen, these cells continue to produce the proteins for at least ®ve days after the infection with recombinant viruses at MOI-value of 10. The production levels of PSA were from ten to twenty times higher than for hK2. Both of the proteins can be easily puri®ed in one step using immuno af®nity chromatography (data not shown).
An epitope map was created for both proteins produced in another insect cell line, Sf 21-cells. The map is shown in Figure 2 . In general, only nine out of 26 Mabs react with hK2 whereas each of the PSA-speci®c Mab react with PSA produced by insect cells. Earlier we have found 15, 16 two major discrepancies relative to puri®ed seminal plasma PSA. Mab H117 is not able to recognize PSA produced by E. coli 15 and Mab H179 is able only to partially recognise hK2 produced by the SFV expression system but only after enzymatic deglycosylation. 16 The former case is presumably due to localisation of the H117 epitope close to the aminoterminal region that was fused into the minor protein III in the phage surface expression system. This fusion is likely to interfere with the structure or accessibility of the epitope. The latter case is most likely a consequence of glycosylation at position 78 in hK2, the residue which is unoccupied in PSA and E. coli produced hK2. An additional anti PSA Mab, namely 66, not previously tested, was found to recognise baculovirus expressed hK2.
The af®nity constants as determined from Scatchardplots (Table 1) show that monoclonal antibodies recognise both proteins produced in insect cells with equal ef®-ciency and identically to PSA puri®ed from seminal plasma with a few exceptions. The af®nity constant of Mab F5 with hK2 is about 30-fold lower than with PSA and the af®nity constant of Mab 2C1 with hK2 is about 3.5-fold smaller than with PSA. We were not able to determine the af®nity constant of Mab H179 to hK2 presumably due to partial glycosylation of the epitope region of this Mab (see above). Other minor differences in the af®nities fall within the imprecision of the af®nity constant determination.
The western-blot for PSA or hK2 produced by insect cells is shown in Figure 3 . As seen both proteins migrate at around 33 kDa which is the estimated size and comparable to that of PSA puri®ed from seminal plasma.
Discussion
We have expressed the genes encoding human prostate speci®c antigen (KLK3) and glandular kallikrein (KLK2) in E. coli, 15, 16 in BHK21 mammalian cell line 17 and in insect cell lines as shown here. The corresponding proteins PSA and hK2, respectively, have been produced. The baculovirus expression system has been extensively used for ef®cient production of various intracellular foreign proteins in levels approaching 0.5 g/l 27 but also applied to the production of extracellular proteins at substantially lower levels, usually in the order of a few mg/l. 28 The expression system produces proteins which are folded properly and in most cases glycosylated at authentic level. The production levels obtained in this study were roughly ten times higher using the recombinant baculovirus expression system cultures ( $ 6 mg/l PSA and $ 300 mg/l hK2) compared to the experiments done with prokaryotic hosts 15, 16 and BHK21-cell line. 17 In earlier reports 29, 30 of insect cell production of PSA considerably lower yields (1±4 mg/L) were obtained.
The proteins were characterised by Western-blotting and epitope mapping using two-site combinations of monoclonal antibodies (Mabs) raised against prostate speci®c antigen. Five different hK2 epitopes could be distinguished, representing nine out of 26 Mabs tested. These ®ve epitopes were not totally independent of each other but rather formed a continuous row of partly overlapping sites as indicated in Figure 2 . Earlier we found that one epitope (H179) apparently is dependent on whether the putative Asn glycosylation site of hK2 is glycosylated or not. 16 In that study we were able to increase the immunoreactivity of H179 for hK2 produced by BHK21 cells by enzymatic deglycosylation reaction (endo F1 PNGase) whereas hK2 produced by E. coli (which is not able to posttranslationally modify proteins with sugar residues) immunoreacted with H179 with an af®nity constant of the same order as PSA puri®ed from seminal¯uid. Similar observation, as that seen for PSA and hK2 expressed in BHK21 cells, was made for hK2 expressed in insect cells. The epitope has however been included in the epitope map of hK2 as it manifests some binding activity to the recombinant hK2 and which activity can be further enhanced by deglycosylating the cell preparation. 16 The af®nities of the Mabs recognising hK2 were generally similar to that of PSA, suggesting the common epitopes seem to contain very conserved structures. However, Map F5 25 originally described by Dr Chu deviated quite considerably from the other four Mabs of its epitope group. The Scatchard plot for its binding to the insect cell produced hK2, in contrast to the insect cell produced PSA or puri®ed PSA, was markedly biphasic and with a substantially lower average af®nity.
Since successful puri®cation of endogenously produced hK2 has only recently been reported, 13 the only available opportunity for us to characterise the speci®city of presently used PSA antibodies and assays was offered through recombinantly produced proteins. Such information enabled us previously 14 to design an indirect but speci®c assay for hK2 in serum using a blocking or scavenger procedure. The validity of the results from such an assay is ultimately dependent on the immunochemical identity between the recombinantly and in vivo produced proteins. Our epitope mapping results from the present study using baculovirus production in insect cells are highly congruent with those previously reported from E. coli and BHK21 expression systems. This provides strong but still indirect evidence for the validity of the serum concentrations with the hK2 assay recently described by us.
The knowledge of the epitopes of PSA and hK2 as well as the af®nities of the Mabs recognising these proteases help in designing immunologic assays speci®c to either one of the highly homologous proteins. Furthermore, the ability to produce these recombinant highly homologous serine proteases of the prostate gland opens up a new possibility for more reliable standardisation of the immunoassays predicting the malignancy or benign status of the prostate. Furthermore, one is now able to raise monoclonal antibodies against hK2 by obtaining a pure source of the protein free of the highly homologous PSA. Both recombinant proteins can be used in immunisations and also in screening of hK2-speci®c antibody producing cell line candidates. Taken together the results may help in designing speci®c diagnostic assays for the assessment of prostate cancer.
